Endocan as a potential biomarker of disease severity and exacerbations in COPD.
Erdal İnMutlu KuluöztürkTeyfik TurgutAyşegül Altıntop GeçkilNevin İlhanPublished in: The clinical respiratory journal (2020)
Endocan may be a novel biomarker for detection of endothelial dysfunction and prediction of exacerbations in patients with COPD.